6-METHYL-5,6,7,8,13,15-HEXAHYDRO-4-H-INDOLO-[4.3A.3.FG]-[3]-BENZAZACYCLOUNDECENE
Compound with spectra: 1 NMR
![6-METHYL-5,6,7,8,13,15-HEXAHYDRO-4-H-INDOLO-[4.3A.3.FG]-[3]-BENZAZACYCLOUNDECENE](/api/compound/5SRdRk1xaZO.png?ph=true&h=300&w=458 "6-METHYL-5,6,7,8,13,15-HEXAHYDRO-4-H-INDOLO-[4.3A.3.FG]-[3]-BENZAZACYCLOUNDECENE")
| SpectraBase Compound ID | 5SRdRk1xaZO |
|---|---|
| InChI | InChI=1S/C20H22N2/c1-22-11-9-15-5-2-3-6-17(15)13-18-14-21-19-8-4-7-16(10-12-22)20(18)19/h2-8,14,21H,9-13H2,1H3 |
| InChIKey | MSXGPWPTXORIBR-UHFFFAOYSA-N |
| Mol Weight | 290.41 g/mol |
| Molecular Formula | C20H22N2 |
| Exact Mass | 290.178299 g/mol |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
2-(4-Chloro-butyrylamino)-3-[4-(3-methyl-butyl)-1H-indol-3-yl]-propionic acid, methyl ester
l-Tryptophan, 4-(3-methyl-2-butenyl)-N-(trifluoroacetyl)-, methyl ester
Azecino[4,5,6-cd]indole-11-carboxylic acid, 2,6,7,10,11,12-hexahydro-8-methyl-, methyl ester
1,3,4,5,6,7-hexahydro-6,7-dioxopyrrolo[4,3,2-fg][3]benzazocine
Methyl 2-(3'-(2-hydroxyethyl)indol-4'-yl)-2-methoxyacetate
Dimethyl-[2-(3,7,8,9-tetrahydropyran[3,2-e]indol-1-yl)ethyl]amine
4-Methoxy-N-iso-propyl-N-methyl-indol-3-ylglyoxylamide
2-TRYPTOPHYL-7,7-DIETHOXYISOQUINUCLIDENE
N-[2-(2-Thiophen-2-yl)ethyl]-N-propyl-N-(6,7,8,9-tetrahydro-3H-benz[e]indol-8-yl)amine
N-ACETYL-4-NITRO-TRYPTOPHAN-METHYLESTER
| Title | Journal or Book | Year |
|---|---|---|
| Dopamine Receptor Ligands. Part 18: Modification of the Structural Skeleton of Indolobenzazecine-Type Dopamine Receptor Antagonists | Journal of Medicinal Chemistry | 2010 |